Shuling
Shuling Cheng, Taipei TW
Patent application number | Description | Published |
---|---|---|
20150223804 | SUTURE DELIVERY DEVICE FOR SUTURING TISSUE - Systems are provided for delivering a suture to close a surgical opening. An elongated deployment member may have at its distal end a retracted counterforce member. The counterforce member may be inserted into the surgical opening and deployed to resist being withdrawn from the opening. A compression member may be slid down the elongated member to compress the tissue to be sutured against the counterforce member. Suture passers loaded with suture ends may be passed through needle tubes within the elongated member to emerge from the elongated member and pierce the tissue to be sutured, then deposit the suture ends with a suture catcher. The suture passers may be withdrawn, leaving the suture ends. The suture catcher may be retracted, retaining the suture ends and the device—elongated member, retracted suture catcher, and retained suture end—may be withdrawn from the surgical opening. The suture may then be completed. | 08-13-2015 |
Shuling Fang, Castro Valley, CA US
Patent application number | Description | Published |
---|---|---|
20080241067 | Methods of Modulating Metastasis and Skeletal Related Events Resulting From Metastases - The invention provides, inter alia, models of bone metastasis, methods for identifying agents that modulate skeletal related events and metastasis, methods for modulating skeletal related events and metastases, and methods for detecting skeletal related events and metastases. The methods and models generally comprise co-culturing cancer cells and host cells and comparing biological markers from such co-cultured cells to control cells. | 10-02-2008 |
Shuling Feng, Saratoga, CA US
Patent application number | Description | Published |
---|---|---|
20160006632 | COMMUNICATION UNIT AND METHOD FOR DETERMINING AND/OR COMPENSATING FOR FREQUENCY DEPENDENT QUADRATURE MISMATCH - A communication unit includes: a quadrature transmitter having analog transmit filter(s) for filtering a first quadrature test signal. An analog feedback loopback path selectively first routes the filtered quadrature first test signal to a quadrature receiver. The quadrature receiver has: at least one analog receive filter for further filtering the filtered quadrature first test signal; and a quadrature receive baseband circuit arranged to receive and decode the further filtered quadrature first test signal. The quadrature transmitter is arranged to receive a second quadrature test signal and the analog feedback loopback path selectively routes a filtered quadrature second test signal to the quadrature receiver via a second route such that the quadrature receive baseband circuit is arranged to determine a frequency-dependent quadrature imbalance of at least one component in the transmitter/receiver based on the decoded further filtered first quadrature test signal and the decoded further filtered second quadrature test signal. | 01-07-2016 |
Shuling Guo, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20140256797 | MODULATION OF TRANSTHYRETIN EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof. | 09-11-2014 |
20140309286 | MODULATION OF TMPRSS6 EXPRESSION - Disclosed herein are antisense compounds and methods for modulating TMPRSS6 and modulating an iron accumulation disease, disorder and/or condition in an individual in need thereof. Iron accumulation diseases in an individual such as hemochromatosis or β-thalassemia can be ameliorated or prevented with the administration of antisense compounds targeted to TM-PRSS6. | 10-16-2014 |
20150087691 | METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION - Disclosed herein are methods for decreasing AIAT mRNA and protein expression and treating, ameliorating, preventing, slowing progression, or stopping progression of fibrosis. Disclosed herein are methods for decreasing AIAT mRNA and protein expression and treating, ameliorating, preventing, slowing progression, or stopping progression of liver disease, such as, AIATD associated liver disease, and pulmonary disease, such as, AIATD associated pulmonary disease in an individual in need thereof. Methods for inhibiting AIAT mRNA and protein expression can also be used as a prophylactic treatment to prevent individuals at risk for developing a liver disease, such as, AIATD associated liver disease and pulmonary disease, such as, AIATD associated pulmonary disease. | 03-26-2015 |
20150252367 | MODULATION OF TRANSTHYRETIN EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof. | 09-10-2015 |
Shuling Li, Sugar Land, TX US
Patent application number | Description | Published |
---|---|---|
20150096827 | COMPRESSIONAL VELOCITY CORRECTION APPARATUS, METHODS, AND SYSTEMS - In some embodiments, an apparatus and a system, as well as a method and an article, may operate to measure compressional wave velocities in a geological formation surrounding a first well, to provide measured compressional wave velocity data, and to subsequently determine corrected compressional wave velocities for the first well. These corrected compressional wave velocities for the first well may be determined using a combination of the measured compressional wave velocity data and corrected compressional wave velocity data associated with one or more second wells. Predicted pore pressure data for the first well may be subsequently generated, using the corrected compressional wave velocities for the first well. Additional apparatus, systems, and methods are described. | 04-09-2015 |
Shuling Li, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20150350923 | NETWORK COVERAGE PLANNING METHOD AND APPARATUS OF EVOLUTION COMMUNICATION SYSTEM - The present invention provides a network coverage planning method and apparatus of an evolution communication system, wherein the method includes: obtaining the theoretical coverage parameter of a single base station of the evolution communication system by link budget; obtaining the theoretical coverage parameter of an entire network of the evolution communication system by network stimulation; calculating a reception level value of the evolution communication system under the wireless environment of a current network communication system in the same planning area to estimate a simulative measured coverage parameter of the evolution communication system; and planning the coverage parameter of the entire network of the evolution communication system according to the theoretical coverage parameter of the single base station, the theoretical coverage parameter of the entire network and the simulative measured coverage parameter. | 12-03-2015 |
Shuling Liu, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20090271635 | METHODS AND SYSTEMS FOR AUTHENTICATION - The present invention discloses a method and system for authentication. The method for authentication includes: acquiring the privilege security level corresponding to a client-end; inquiring the identity security level corresponding to the privilege security level according to an established relation of association between privilege security level and identity security level; determining the authentication parameters for identity authentication according to the identity security level; performing identity authentication on the client-end using the authentication parameters; and obtaining an authentication result. The identity authentication and privilege authentication are combined, and identity authentication is performed according to the identity security level in accord with the privilege security level so that rules of identity authentication can be adjusted, and the flexibility of the process of authentication may be improved. | 10-29-2009 |
Shuling Sun, Beijing CN
Patent application number | Description | Published |
---|---|---|
20140001090 | PROCESS FOR HYDROTREATING HEAVY RAW OILS | 01-02-2014 |
Shuling Yang, Beijing CN
Patent application number | Description | Published |
---|---|---|
20100184661 | CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF - The present invention provides an anti-tumor or anti-angiogenesis medicament, the combination or kit containing the medicament, and the method for producing the same. The anti-tumor or anti-angiogenesis medicament contains a conjugate comprising a modifying agent and the angiostatin or its fragments, wherein the conjugate exhibits prolonged in vivo half-life as compared to an unmodified angiostatin or its fragments. The modifying agent is selected from the group consisting of macromolecular polymers, protein molecules or fragments thereof, peptides, small molecules, or chemical substances of any other forms. | 07-22-2010 |
20140056966 | CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE CONJUGATE AND USE THEREOF - The present invention provides an anti-tumor or anti-angiogenesis medicament, the combination or kit containing the medicament, and the method for producing the same. The anti-tumor or anti-angiogenesis medicament contains a conjugate comprising a modifying agent and the angiostatin or its fragments, wherein the conjugate exhibits prolonged in vivo half-life as compared to an unmodified angiostatin or its fragments. The modifying agent is selected from the group consisting of macromolecular polymers, protein molecules or fragments thereof, peptides, small molecules, or chemical substances of any other forms. | 02-27-2014 |
Shuling Zheng US
Patent application number | Description | Published |
---|---|---|
20150353565 | BTK INHIBITORS - The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders. | 12-10-2015 |
Shuling Zheng, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20150353565 | BTK INHIBITORS - The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders. | 12-10-2015 |